Cross-reactivity in grasses: Biochemical attributes define exemplar relevance

World Allergy Organization Journal

Volumn 5, Issue 10, 2012, Pages 111-119

  Bullimore, Alan ^a   Batten, Toby ^a   Hewings, Simon ^a   Von Weikersthal Drachenberg, Karl Juergen Fischer ^a   Skinner, Murray ^a  

^a Research and Development   (United Kingdom)

Author keywords

Allergens; Characterization; Grass; Homology; Immunotherapy

Indexed keywords

EPITOPE; GRASS POLLEN EXTRACT; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; POLLEN ANTIGEN;

ALLERGY; ANTIGEN SPECIFICITY; ARTICLE; CLINICAL ARTICLE; COMPUTER PROGRAM; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GEL ELECTROPHORESIS PROTEIN PROFILE ANALYSIS; GRASS; GRASS POLLEN; HUMAN; IMMUNE RESPONSE; IMMUNOTHERAPY; IN VITRO STUDY; MALE; NONHUMAN; POLLEN ALLERGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONTENT; QUANTITATIVE ANALYSIS; SPECIES COMPARISON; SPECIFIC IMMUNOTHERAPY; WESTERN BLOTTING;

EID: 84868612143     PISSN: 19394551     EISSN: None     Source Type: Journal    
DOI: 10.1097/WOX.0b013e31826a10cf     Document Type: Article

References (22)

1. Freidhoff LR, Ehrlich-Kautzky E, Grant JH, Meyers DA, Marsh DG. A study of the human immune response to Lolium perenne (rye) pollen and its components, Lol, p. I and Lol, p. II (rye I rye II). Prevalence of reactivity to the allergens and correlations among skin test, IgE antibody, and IgG antibody data. J Allergy Clin Immunol. 1986;78:1190-1201. (Pubitemid 17227467)
2. Andersson K, Lidholm J. Characteristics and immunobiology of grass pollen allergens. Int Arch Allergy Immunol. 2003;130:87-107. (Pubitemid 36351233)
3. Schmid-Grendelmeier P. Rekombinante allergene, routinediagnostik oder wissenschaft? Hautarzt. 2010;61:946-953.
4. Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: Therapeutic vaccines for allergic diseases. A who position paper. J Allergy Clin Immunol. 1998;102:558-562.
5. Till SJ, Durham SR. Immunological responses to allergen immunotherapy. Clin Allergy Immunol. 2004;18:85-104.
6. Till SJ, Francis JN, Nouri-Aria K, Durham SR. Mechanisms of immunotherapy. J Allergy Clin Immunol. 2004;113:1025-1035.
7. Durham SR, Ying S, Varney VA, Jacobson MR, Sudderick RM, et al. Grass pollen immunotherapy inhibits allergen-induced infiltration of CD41 T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma. J Allergy Clin Immunol. 1996;97:1356-1365.
8. Evans R, Pence H, Kaplan H, Rocklin RE. The effect of immunotherapy on humoral and cellular responses in ragweed hayfever. J Clin Invest. 1976;57:1378-1385.
9. Hamid QA, Schotman E, Jacobson MR, Walker SM, Durham SR. Increases in IL-12 messenger RNA1 cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy. J Allergy Clin Immunol. 1997;99:254-260. (Pubitemid 27091578)
10. Tulic MK, Fiset PO, Christodoulopoulos P, Vaillancourt P, Desrosiers M, et al. Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response. J Allergy Clin Immunol. 2004;113:235-241. (Pubitemid 38210543)
11. Bellinghausen I, Metz G, Enk AH, Christmann S, Knop J, et al. Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venomallergic subjects. Eur J Immunol. 1997;27:1131-1139. (Pubitemid 27197215)
12. Blaser K, Akdis CA. Interleukin-10, T regulatory cells and specific allergy treatment. Clin Exp Allergy. 2004;34:328-331. (Pubitemid 38372992)
13. Francis JN, Till SJ, Durham SR. Induction of IL-101CD41CD251 T cells by grass pollen immunotherapy. J Allergy Clin Immunol. 2003;111:1255-1261. (Pubitemid 36683679)
14. Jutel M, Akdis M, Budak F, Aebischer-Casaulta C, Wrzyszcz M, Blaser K, Akdis CA. IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol. 2003;33:1205-1214. (Pubitemid 36609138)
15. Savolainen J, Laaksonen K, Rantio-Lehtimaki A, Terho EO. Increased expression of allergen-induced in vitro interleukin-10 and interleukin-18 mRNA in peripheral blood mononuclear cells of allergic rhinitis patients after specific immunotherapy. Clin Exp Allergy. 2004;34:413-419. (Pubitemid 38373004)
16. Hrabina M, Peltre G, Van Ree R, Moingeon P. Grass Pollen Allergens. Clin Exp Allergy. 2008;8:7-11. (Pubitemid 351502687)
17. Hejl C, Wurtzen PA, Kleine-Tebbe J, Johansen N, Broge L, Ipsen H. Phleum pratense alone is sufficient for allergen-specific immunotherapy against allergy to Pooideae grass pollens. Clin Exp Allergy. 2009;39:752-759.
18. Lorenz AR, Lüttkopf D, May S, Scheurer S, Vieths S. The principle of homologous groups in regulatory affairs of allergen productsda proposal. Int Arch Allergy Immunol. 2009;148:1-17.
19. Moingeon P, Hrabina M, Bergmann KC, Jaeger S, Frati F, Bordas V, Peltre G. Specific immunotherapy for common grass pollen allergies: pertinence of a five grass vaccine. Int Arch Allergy Immunol. 2008;146:338-342. (Pubitemid 351957409)
20. Du Buske LM, Frew AJ, Horak F, Keith PK, Corrigan CJ, et al. Ultrashortspecific immunotherapy successfully treats seasonal allergic rhinoconjunctivitis to grass pollen. Allergy Asthma Proc. 2011;32:239-247.
21. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
22. Bullimore A, Swan N, Alawode W, Skinner M. A proteomic style approach to standardise a grass mix products reveals potential immunotherapeutic benefit. WAO J. 2011;4:140-146.